Combinations comprising alpha-2-delta ligands and EP4 receptor antagonists

Details for Australian Patent Application No. 2005235248 (hide)

Owner Pfizer Products Inc.

Inventors Audoly, Laurent Pascal

Agent Shelston IP

Pub. Number AU-A-2005235248

PCT Pub. Number WO2005/102389

Priority 60/563,863 20.04.04 US

Filing date 8 April 2005

Wipo publication date 3 November 2005

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/196 (2006.01)

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/102389 Priority application(s): WO2005/102389

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235254-Lozenge for delivery of dextromethorphan

2005235239-Gastric retention system